Matthew T. Wiley - Chief Commercial Officer at BioXcel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Issuer Symbol
BTAI on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew T. Wiley since 13 Feb 2025

Holdings reported by Matthew T. Wiley for BioXcel Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 19,011 $10,456 $0.5500 03 Oct 2024 Direct
Restricted Stock Units 7,500 $9,600 $1.28 15 Sep 2024 Direct Common Stock
Stock Option (right to buy) 1,875 22 Jul 2024 Direct Common Stock

Transactions reported by Matthew T. Wiley for BioXcel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.